2 completed, 2 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Unknown 2 |
| Phase 2 | 1 | Completed 1 |
Follow Tuberculin: new trials by email Literature Review of Tuberculin trials Research Report on Tuberculin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above Recombinant Mycobacterium Tuberculosis Fusion Protein, Purified Protein Derivative of Tuberculin - Latent Tuberculosis Infection | Phase 3 | Completed | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 780 | 2023-08-03 | 2026-04-30 |
| Triple Antigen vs Monoantigen Immunotherapy for Warts Intralesional antigen immunotherapy - Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts | Phase 2 / Phase 3 | Completed | Zagazig University | 160 | 2020-11-20 | 2022-02-24 |
| Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts Tuberculin purified protein derivative - Common Wart | Phase 3 | Unknown | Assiut University | 40 | 2020-03-01 | 2020-02-28 |
| Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients tuberculin, cryotherapy - Genital Wart | Phase 3 | Unknown | Assiut University | 45 | 2017-06-01 | 2017-05-17 |
Warts (2) · Condylomata Acuminata (1) · Latent Tuberculosis (1)
Assiut University (2) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (1) · Zagazig University (1)
China (1) · Egypt (1)
PMID 11238198, PMID 12807939, PMID 15897380, PMID 16973081, PMID 23336207, PMID 25273231, PMID 36705474